Aptevo Therapeutics Inc.
APVO· Nasdaq
APVOAptevo Therapeutics Inc.
Source filing unavailable
| Metric | Q1 2016 | Q1 2015 |
|---|---|---|
| Revenue | $8.07M | $11.66M |
| Net Income | -$12.89M | -$11.02M |
| EPS Diluted | -$0.64 | -$0.54 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aptevo Therapeutics Inc. · CIK 1671584 · Engraved from SEC EDGAR
